A major review has concluded that paracetamol use during pregnancy is not causally linked to neurodevelopmental disorders, according to News-Medical. The finding, reported on 23 September 2026, covers conditions including autism and ADHD.
News-Medical reports that the study found no causal association between prenatal exposure to the painkiller and these disorders. The review's conclusion was also carried by CIDRAP, which described the work as a major review, and by Forbes, which reported that no convincing link was found between Tylenol in pregnancy and autism.
Paracetamol, sold under brand names including Tylenol, is a common pain and fever medication. Questions about its safety during pregnancy have circulated for years, and the new review addresses whether the medication itself causes the conditions in question. According to the coverage, the evidence does not support a causal relationship.
The reports do not include details of the study's methodology, the number of studies reviewed, or the institutions involved, so those specifics remain unavailable in the material summarized here. What the coverage does establish is the central conclusion: the review found no causal link, and the outlets reporting on it characterized the finding as significant enough to warrant wide coverage.
For now, the takeaway from the reporting is that pregnant women and their clinicians have a clearer picture of the evidence on this question than before. Further details of the review, including its full methods and any accompanying commentary from researchers or medical bodies, are expected to emerge as the study circulates more widely.
